Tsay G J, Fann R H, Hwang J
Department of Internal Medicine, Chung Shan Medical and Dental College, Taichung, ROC.
J Rheumatol. 1990 Oct;17(10):1314-9.
A large scale purification of DNA topoisomerase I from calf thymus was obtained using the combinations of 62% ammonium sulfate precipitation, Biorex 70, hydroxylapatite and phenylagarose chromatography. Silver staining of the preparation separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis revealed 2 bands of apparent molecular weight of 70 and 60 kDa. Immunoblotting with a serum of anti-Scl-70 specificity also recognized both proteins. Anti-Scl-70 antibodies were detected in 24/32 (75%) patients with diffuse scleroderma by ELISA and 28/32 (87%) had the ability to neutralize the topoisomerase I activity. All of 14 sera with anticentromere antibodies did not react with DNA topoisomerase I by both assays. The presence of anti-Scl-70 antibodies remained disease specific despite the increase in sensitivity of both assays.
通过62%硫酸铵沉淀、Bio-Rex 70、羟基磷灰石和苯琼脂糖层析相结合的方法,从牛胸腺中大规模纯化了DNA拓扑异构酶I。用十二烷基硫酸钠-聚丙烯酰胺凝胶电泳分离制备物并进行银染,显示出两条表观分子量分别为70 kDa和60 kDa的条带。用具有抗Scl-70特异性的血清进行免疫印迹也识别这两种蛋白质。通过ELISA在24/32(75%)弥漫性硬皮病患者中检测到抗Scl-70抗体,28/32(87%)的患者血清具有中和拓扑异构酶I活性的能力。在两种检测方法中,所有14份含有抗着丝粒抗体的血清均不与DNA拓扑异构酶I发生反应。尽管两种检测方法的灵敏度有所提高,但抗Scl-70抗体的存在仍具有疾病特异性。